Moneycontrol PRO

business

Alembic Pharma expects API biz to grow 10% in FY15

The growth for the international generics, however, remain muted at about 9 percent due to higher base last year.

first published: Oct 20, 2014 04:08 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347